RECIST, iRECIST & mRECIST
How three competing frameworks for measuring tumor response are reshaping the science — and the business — of cancer drug development In the middle of a clinical trial, a radiologist looks at a scan and sees a tumor that has grown. Under the rules that have governed oncology research for decades, the conclusion would […]
RECIST, iRECIST & mRECIST Read More »